Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2002 Oct;78(924):575–583. doi: 10.1136/pmj.78.924.575

Diagnosis and treatment of viral encephalitis

A Chaudhuri 1, P Kennedy 1
PMCID: PMC1742520  PMID: 12415078

Abstract

Acute encephalitis constitutes a medical emergency. In most cases, the presence of focal neurological signs and focal seizures will distinguish encephalitis from encephalopathy. Acute disseminated encephalomyelitis is a non-infective inflammatory encephalitis that may require to be treated with steroids. Acute infective encephalitis is usually viral. Herpes simplex encephalitis (HSE) is the commonest sporadic acute viral encephalitis in the Western world. Magnetic resonance imaging of brain is the investigation of choice in HSE and the diagnosis may be confirmed by the polymerase chain reaction test for the virus in the cerebrospinal fluid. In this article, we review the diagnosis, investigations, and management of acute encephalitis. With few exceptions (for example, aciclovir for HSE), no specific therapy is available for most forms of viral encephalitis. Mortality and morbidity may be high and long term sequelae are known among survivors. The emergence of unusual forms of zoonotic encephalitis has posed an important public health problem. Vaccination and vector control measures are useful preventive strategies in certain arboviral and zoonotic encephalitis. However, we need better antiviral therapy to meet the challenge of acute viral encephalitis more effectively.

Full Text

The Full Text of this article is available as a PDF (156.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amore M., Zazzeri N. Neuroleptic malignant syndrome after neuroleptic discontinuation. Prog Neuropsychopharmacol Biol Psychiatry. 1995 Dec;19(8):1323–1334. doi: 10.1016/0278-5846(95)00269-3. [DOI] [PubMed] [Google Scholar]
  2. Arribas J. R., Storch G. A., Clifford D. B., Tselis A. C. Cytomegalovirus encephalitis. Ann Intern Med. 1996 Oct 1;125(7):577–587. doi: 10.7326/0003-4819-125-7-199610010-00008. [DOI] [PubMed] [Google Scholar]
  3. Balfour H. H., Jr Antiviral drugs. N Engl J Med. 1999 Apr 22;340(16):1255–1268. doi: 10.1056/NEJM199904223401608. [DOI] [PubMed] [Google Scholar]
  4. Behan P. O., Bakheit A. M. Clinical spectrum of postviral fatigue syndrome. Br Med Bull. 1991 Oct;47(4):793–808. doi: 10.1093/oxfordjournals.bmb.a072511. [DOI] [PubMed] [Google Scholar]
  5. Demaerel P., Wilms G., Robberecht W., Johannik K., Van Hecke P., Carton H., Baert A. L. MRI of herpes simplex encephalitis. Neuroradiology. 1992;34(6):490–493. doi: 10.1007/BF00598957. [DOI] [PubMed] [Google Scholar]
  6. Duggan A. J., Hutchinson M. P. Sleeping sickness in Europeans: a review of 109 cases. J Trop Med Hyg. 1966 Jun;69(6):124–131. [PubMed] [Google Scholar]
  7. Enting R., de Gans J., Reiss P., Jansen C., Portegies P. Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS. Lancet. 1992 Aug 29;340(8818):559–560. doi: 10.1016/0140-6736(92)91764-y. [DOI] [PubMed] [Google Scholar]
  8. Fodor P. A., Levin M. J., Weinberg A., Sandberg E., Sylman J., Tyler K. L. Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology. 1998 Aug;51(2):554–559. doi: 10.1212/wnl.51.2.554. [DOI] [PubMed] [Google Scholar]
  9. Furman P. A., St Clair M. H., Spector T. Acyclovir triphosphate is a suicide inactivator of the herpes simplex virus DNA polymerase. J Biol Chem. 1984 Aug 10;259(15):9575–9579. [PubMed] [Google Scholar]
  10. Goh K. J., Tan C. T., Chew N. K., Tan P. S., Kamarulzaman A., Sarji S. A., Wong K. T., Abdullah B. J., Chua K. B., Lam S. K. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000 Apr 27;342(17):1229–1235. doi: 10.1056/NEJM200004273421701. [DOI] [PubMed] [Google Scholar]
  11. Höllinger P., Matter L., Sturzenegger M. Normal MRI findings in herpes simplex virus encephalitis. J Neurol. 2000 Oct;247(10):799–801. doi: 10.1007/s004150070096. [DOI] [PubMed] [Google Scholar]
  12. Ito Y., Kimura H., Yabuta Y., Ando Y., Murakami T., Shiomi M., Morishima T. Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin Infect Dis. 2000 Jan;30(1):185–187. doi: 10.1086/313618. [DOI] [PubMed] [Google Scholar]
  13. Kennedy P. G. A retrospective analysis of forty-six cases of herpes simplex encephalitis seen in Glasgow between 1962 and 1985. Q J Med. 1988 Jul;68(255):533–540. [PubMed] [Google Scholar]
  14. Kennedy P. G. The widening spectrum of infectious neurological disease. J Neurol Neurosurg Psychiatry. 1990 Aug;53(8):629–632. doi: 10.1136/jnnp.53.8.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Koskiniemi M., Rantalaiho T., Piiparinen H., von Bonsdorff C. H., Färkkilä M., Järvinen A., Kinnunen E., Koskiniemi S., Mannonen L., Muttilainen M. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol. 2001 Oct;7(5):400–408. doi: 10.1080/135502801753170255. [DOI] [PubMed] [Google Scholar]
  16. Laskin O. L., Stahl-Bayliss C. M., Morgello S. Concomitant herpes simplex virus type 1 and cytomegalovirus ventriculoencephalitis in acquired immunodeficiency syndrome. Arch Neurol. 1987 Aug;44(8):843–847. doi: 10.1001/archneur.1987.00520200047017. [DOI] [PubMed] [Google Scholar]
  17. Launes J., Nikkinen P., Lindroth L., Brownell A. L., Liewendahl K., Iivanainen M. Diagnosis of acute herpes simplex encephalitis by brain perfusion single photon emission computed tomography. Lancet. 1988 May 28;1(8596):1188–1191. doi: 10.1016/s0140-6736(88)92010-7. [DOI] [PubMed] [Google Scholar]
  18. Launes J., Sirén J., Valanne L., Salonen O., Nikkinen P., Seppäläinen A. M., Liewendahl K. Unilateral hyperfusion in brain-perfusion SPECT predicts poor prognosis in acute encephalitis. Neurology. 1997 May;48(5):1347–1351. doi: 10.1212/wnl.48.5.1347. [DOI] [PubMed] [Google Scholar]
  19. Nash D., Mostashari F., Fine A., Miller J., O'Leary D., Murray K., Huang A., Rosenberg A., Greenberg A., Sherman M. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001 Jun 14;344(24):1807–1814. doi: 10.1056/NEJM200106143442401. [DOI] [PubMed] [Google Scholar]
  20. Pradhan S., Pandey N., Shashank S., Gupta R. K., Mathur A. Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology. 1999 Nov 10;53(8):1781–1786. doi: 10.1212/wnl.53.8.1781. [DOI] [PubMed] [Google Scholar]
  21. Safrin S., Crumpacker C., Chatis P., Davis R., Hafner R., Rush J., Kessler H. A., Landry B., Mills J. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med. 1991 Aug 22;325(8):551–555. doi: 10.1056/NEJM199108223250805. [DOI] [PubMed] [Google Scholar]
  22. Schroth G., Gawehn J., Thron A., Vallbracht A., Voigt K. Early diagnosis of herpes simplex encephalitis by MRI. Neurology. 1987 Feb;37(2):179–183. doi: 10.1212/wnl.37.2.179. [DOI] [PubMed] [Google Scholar]
  23. Selvey L. A., Wells R. M., McCormack J. G., Ansford A. J., Murray K., Rogers R. J., Lavercombe P. S., Selleck P., Sheridan J. W. Infection of humans and horses by a newly described morbillivirus. Med J Aust. 1995 Jun 19;162(12):642–645. doi: 10.5694/j.1326-5377.1995.tb126050.x. [DOI] [PubMed] [Google Scholar]
  24. Sköldenberg B., Forsgren M., Alestig K., Bergström T., Burman L., Dahlqvist E., Forkman A., Frydén A., Lövgren K., Norlin K. Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. Lancet. 1984 Sep 29;2(8405):707–711. doi: 10.1016/s0140-6736(84)92623-0. [DOI] [PubMed] [Google Scholar]
  25. Steele K. E., Linn M. J., Schoepp R. J., Komar N., Geisbert T. W., Manduca R. M., Calle P. P., Raphael B. L., Clippinger T. L., Larsen T. Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol. 2000 May;37(3):208–224. doi: 10.1354/vp.37-3-208. [DOI] [PubMed] [Google Scholar]
  26. Studahl M., Ricksten A., Sandberg T., Bergström T., Elowson S. Cytomegalovirus encephalitis in four immunocompetent patients. Lancet. 1992 Oct 24;340(8826):1045–1046. doi: 10.1016/0140-6736(92)93068-x. [DOI] [PubMed] [Google Scholar]
  27. Tyler K. L. West Nile virus encephalitis in America. N Engl J Med. 2001 Jun 14;344(24):1858–1859. doi: 10.1056/NEJM200106143442409. [DOI] [PubMed] [Google Scholar]
  28. Whitley R. J., Alford C. A., Hirsch M. S., Schooley R. T., Luby J. P., Aoki F. Y., Hanley D., Nahmias A. J., Soong S. J. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16;314(3):144–149. doi: 10.1056/NEJM198601163140303. [DOI] [PubMed] [Google Scholar]
  29. Whitley R. J., Soong S. J., Dolin R., Galasso G. J., Ch'ien L. T., Alford C. A. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11;297(6):289–294. doi: 10.1056/NEJM197708112970601. [DOI] [PubMed] [Google Scholar]
  30. Whitley R. J., Soong S. J., Linneman C., Jr, Liu C., Pazin G., Alford C. A. Herpes simplex encephalitis. Clinical Assessment. JAMA. 1982 Jan 15;247(3):317–320. [PubMed] [Google Scholar]
  31. Whitley R. J. Viral encephalitis. N Engl J Med. 1990 Jul 26;323(4):242–250. doi: 10.1056/NEJM199007263230406. [DOI] [PubMed] [Google Scholar]
  32. Whitley Richard J., Gnann John W. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 2002 Feb 9;359(9305):507–513. doi: 10.1016/S0140-6736(02)07681-X. [DOI] [PubMed] [Google Scholar]
  33. Yanagisawa N., Toyokura Y., Shiraki H. Double encephalitis with herpes simplex virus and cytomegalovirus in an adult. Acta Neuropathol. 1975 Dec 8;33(2):153–164. doi: 10.1007/BF00687541. [DOI] [PubMed] [Google Scholar]
  34. Zimmerman R. D., Russell E. J., Leeds N. E., Kaufman D. CT in the early diagnosis of herpes simplex encephalitis. AJR Am J Roentgenol. 1980 Jan;134(1):61–66. doi: 10.2214/ajr.134.1.61. [DOI] [PubMed] [Google Scholar]
  35. de Miranda P., Blum M. R. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother. 1983 Sep;12 (Suppl B):29–37. doi: 10.1093/jac/12.suppl_b.29. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES